• Stigma, hope and TRACERx: 20 years of understanding lung cancer

  • Nov 1 2022
  • Length: 30 mins
  • Podcast

Stigma, hope and TRACERx: 20 years of understanding lung cancer

  • Summary

  • This episode features Professor Charles Swanton. Charlie is Cancer Research UK's Chief Clinician and his lab at the Francis Crick Institute studies lung cancer tumour heterogeneity and maps the evolutionary pathways at work as cancers evolve and change.


    He talks about the profound changes in the way the research community thinks about lung cancer, the power of the translational mind-set and delves into the flagship project, TRACERx.


    He also talks briefly about his lab’s growing interest in the mechanistic links between air pollution and lung cancer in never smokers.


    Useful links

    Explore how Cancer Research Horizons can help you translate your work

    https://www.cancerresearchhorizons.com/our-expertise/research-translation


    Read about Charlie’s work on air pollution and lung cancer https://news.cancerresearchuk.org/2021/12/13/its-a-fair-cop-why-our-chief-clinician-went-to-a-climate-change-summit/


    ScottishPower and Cancer Research UK, working together for a greener, healthier future

    Our longstanding partner ScottishPower is helping us shine a light on the role air pollution plays in cancer and are covering the cost of a study called TOPICAL. ScottishPower is 100% committed to helping tackle climate change and our partnership reflects our shared interest in a greener, healthier future.



    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Stigma, hope and TRACERx: 20 years of understanding lung cancer

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.